Telehealth SUD Treatment Needs More Research, Oversight

A growing amount of treatment for substance use disorders (SUDs) has moved to telehealth providers due to the COVID-19 pandemic. This trend likely increased patients’ access to treatment, among other benefits, but researchers and plan sponsors say that the efficacy and value of virtual care modalities in SUD settings is still an open question.

0 Comments
© 2023 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

injection-pen
November 22

Medicare Part D Coverage for Humira Biosimilars Has Inspector General’s Attention

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
November 22

News Briefs: Nearly 4.6M People Have Enrolled in ACA Exchange Plans for 2024

READ MORE
wall-street
November 22

Elevated Outpatient Care, No Recession: 2023 Has Surprised Analysts

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today